Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

6.41
Delayed Data
As of Sep 23
 +0.15 / +2.40%
Today’s Change
5.18
Today|||52-Week Range
11.26
-38.19%
Year-to-Date
Here's Why TherapeuticsMD Inc. Fell 11.5% in August
Sep 12 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close6.26
Today’s open6.26
Day’s range6.18 - 6.43
Volume1,912,065
Average volume (3 months)1,285,835
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 09/23/2016

Growth & Valuation

Earnings growth (last year)-36.11%
Earnings growth (this year)+12.24%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+34.05%
P/E ratioNM
Price/Sales89.15
Price/Book18.09

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...+0.06+0.22%
INVAInnoviva Inc+0.01+0.09%
SUPNSupernus Pharmaceuti...+0.15+0.58%
CEMPCempra Inc+0.61+2.48%
Data as of 3:59pm ET, 09/23/2016

Financials

Next reporting dateNovember 2, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$20.1M
Annual profit (last year)-$85.1M
Net profit margin-422.37%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts

Search for Jobs